Purify
Viral Vector Downstream Process

The gene therapy industry is facing increasing pressure to decrease manufacturing costs, shorten process development timelines and increase production. However, most virus purification processes today still rely heavily on legacy process technologies that require significant capital and labor investments while offering low yield, throughput and lack of flexibility.

Our downstream processes help improve yield and productivity thus decreasing costs and timelines.